Európska únia - maltčina - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - lamivudine - epatite b, kronika - antivirali għal użu sistemiku - zeffix is indicated for the treatment of chronic hepatitis b in adults with: , compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active liver inflammation and / or fibrosis. il-bidu tal-kura b'lamivudine għandhom jiġu kkunsidrati biss meta l-użu ta ' sustanza antivirali alternattiva bl-ogħla ġenetiċi barriera ma tkunx disponibbli jew ikun xieraq;, mard tal-fwied dekompensat flimkien mal-tieni aġent mingħajr kross-reżistenza għal lamivudine.

Európska únia - maltčina - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - ziconotide - injections, spinal; pain - analġeżiċi - ziconotide huwa indikat għall-kura ta 'uġigħ sever u kroniku f'pazjenti li jeħtieġu analġeżija intrateġika (it).

Európska únia - maltčina - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Európska únia - maltčina - EMA (European Medicines Agency)

novo nordisk a/s - insulina umana - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Európska únia - maltčina - EMA (European Medicines Agency)

novo nordisk a/s - insulin aspart - diabetes mellitus - drugs used in diabetes, insulins and analogues for injection, fast-acting - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal ta 'sena u aktar.

Európska únia - maltčina - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Európska únia - maltčina - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Európska únia - maltčina - EMA (European Medicines Agency)

novo nordisk a/s - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Európska únia - maltčina - EMA (European Medicines Agency)

novo nordisk a/s - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - novorapid huwa indikat għat-trattament tad-dijabete mellitus f'adulti, adoloxxenti u tfal ta 'sena u aktar.

Európska únia - maltčina - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.